Literature DB >> 32935606

Medicolegal Implications of Mild Neurocognitive Disorder.

Anca Bejenaru1, James M Ellison1,2,3.   

Abstract

INTRODUCTION: The syndromes of mild cognitive impairment (MCI) or mild neurocognitive disorder (MiND), often prodromal to dementia (Major Neurocognitive Disorder), are characterized by acquired clinically significant changes in one or more cognitive domains despite preserved independence. Mild impairment has significant medicolegal consequences for an affected person and their care system. We review the more common etiologies of MiND and provide a systematic review of its medicolegal implications.
METHODS: We conducted a systematic review of the peer-reviewed English literature on medicolegal aspects of MCI or MiND using comprehensive search terms and expanding our review to include sources cited by these reports.
RESULTS: Impairment of memory, executive function, social cognition, judgment, insight or abstraction can alter an individual's abilities in a variety of areas that include decision making, informed consent, designation of a surrogate decision-maker such as a health care proxy, understanding and management of financial affairs, execution of a will, or safe driving.
CONCLUSION: Even mild cognitive impairment can have significant behavioral consequences. Clinicians can assist care partners and persons with MCI or MiND by alerting them to the medicolegal concerns that often accompany cognitive decline. Early recognition and discussion can help a care system manage medicolegal risk more effectively and promote thoughtful advance planning.

Entities:  

Keywords:  capacity; forensic; medicolegal; mild cognitive impairment; mild neurocognitive disorder; surrogate; will

Mesh:

Year:  2020        PMID: 32935606     DOI: 10.1177/0891988720957092

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  1 in total

1.  Disclosure of a Dementia Diagnosis:: Minimizing Medical Trauma.

Authors:  James M Ellison; Sehba Husain-Krautter
Journal:  Dela J Public Health       Date:  2022-05-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.